What is Bausch Health Companies's bausch + lomb — SG&A?

Bausch Health Companies (BHC) reported bausch + lomb — SG&A of $439M in Q1 2026.

How has Bausch Health Companies's bausch + lomb — SG&A changed year-over-year?

Bausch Health Companies's bausch + lomb — SG&A decreased by 1.8% year-over-year, from $447M to $439M.

What is the long-term trend for Bausch Health Companies's bausch + lomb — SG&A?

Over 3 years (2022 to 2025), Bausch Health Companies's bausch + lomb — SG&A has grown at a 12.5% compound annual growth rate (CAGR), from $1.25B to $1.78B.

What does bausch + lomb — SG&A mean?

Includes all non-production costs associated with operating the Bausch + Lomb segment, such as marketing, sales force expenses, and corporate overhead. Monitoring this metric helps assess the operational efficiency and cost-to-serve ratio of the segment's business model.

Bausch Health Companies (BHC) Bausch + Lomb — SG&A

Screener

Other segment segments

Salix

$105M-5.4%

International

$63M+21.2%

Diversified

$43M-4.4%

Solta Medical

$35M+25.0%

Similar metrics at other companies

LENCentral — SG&A

$148.21M-2.7%

LENEast — SG&A

$162.77M+0.4%

LENHomebuilding — SG&A

$617.5M+0.3%

LENOther — SG&A

$7.71M+91.6%

LENWest — SG&A

$191.17M-5.5%

COSTCanada — SG&A

$2.2B+11.3%

Other financials

Income statement

See full

Revenue$2.5B+11.7%

Operating income-$950.0M-444%

Net income-$1.4B-2,353%

EPS (diluted)-$3.82-2,287%

Balance sheet

See full

Cash & equivalents$1.3B+13.4%

Total debt$20.8B-3.5%

Total equity-$2.1B-74.0%

Total assets$24.5B-7.3%

Cash flow

See full

Operating cash flow$230.0M+9.0%

CapEx$109.0M-5.2%

Free cash flow$121.0M+26.0%

Valuation

See full

Market cap$2.21B+3.8%

Enterprise value$21.66B-2.1%

P/S0.2×0.0×

Profitability

See full

Gross margin71.4%—

Operating margin5.6%-10.3pp

Net margin-1.9%-0.9pp

FCF margin9.8%-2.8pp

Returns & leverage

See full

Return on equity-70.1%—

Debt / equity45.2×—

Current ratio1.3×0.0×

Where this comes from

Reported directly by Bausch Health Companies in its filing.

Tagged under the XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense.

The source filing: Bausch Health Companies’s 10-Q, filed April 30, 2026.

Filed: Apr 29, 2026, 6:12 PM EDT
Fiscal quarter: Q1 FY2026
Calendar quarter: Q1 2026
Accession: 0000885590-26-000053

(in millions)	Three Months Ended March 31, / Salix / 2026	Three Months Ended March 31, / Salix / 2025	Three Months Ended March 31, / International / 2026	Three Months Ended March 31, / International / 2025	Three Months Ended March 31, / Solta Medical / 2026	Three Months Ended March 31, / Solta Medical / 2025	Three Months Ended March 31, / Diversified / 2026	Three Months Ended March 31, / Diversified / 2025	Three Months Ended March 31, / Bausch + Lomb / 2026	Three Months Ended March 31, / Bausch + Lomb / 2025	Three Months Ended March 31, / Total / 2026	Total / 2025
Less:
Cost of goods sold (a)	47	43	112	102	53	27	27	30	482	481
Cost of other revenues	—	—	16	17	—	—	—	—	1	1
Selling, general and administrative	105	111	63	52	35	28	43	45	439	447
Research and development	19	17	6	6	8	5	3	3	45	28
Segment profit	$468	$371	$88	$85	$75	$53	$112	$127	$277	$180	$1,020	$816
Corporate											(258)	(268)
Amortization of intangible assets											(241)	(256)

Item 1. Condensed Consolidated Financial Statements (unaudited)

FAQ

What is Bausch Health Companies's bausch + lomb — SG&A?: Bausch Health Companies (BHC) reported bausch + lomb — SG&A of $439M in Q1 2026.
How has Bausch Health Companies's bausch + lomb — SG&A changed year-over-year?: Bausch Health Companies's bausch + lomb — SG&A decreased by 1.8% year-over-year, from $447M to $439M.
What is the long-term trend for Bausch Health Companies's bausch + lomb — SG&A?: Over 3 years (2022 to 2025), Bausch Health Companies's bausch + lomb — SG&A has grown at a 12.5% compound annual growth rate (CAGR), from $1.25B to $1.78B.
What does bausch + lomb — SG&A mean?: Includes all non-production costs associated with operating the Bausch + Lomb segment, such as marketing, sales force expenses, and corporate overhead. Monitoring this metric helps assess the operational efficiency and cost-to-serve ratio of the segment's business model.